Net Change In Cash - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GlaxoSmithKline PLC
Net Change in Cash Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Net Change in Cash
-ÂŁ159m
CAGR 3-Years
67%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
AstraZeneca PLC
NASDAQ:AZN
Net Change in Cash
$1.2B
CAGR 3-Years
-50%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Net Change in Cash
-$290m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Net Change in Cash
-$36m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Allergy Therapeutics PLC
LSE:AGY
Net Change in Cash
-ÂŁ1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Net Change in Cash
-ÂŁ46.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is GlaxoSmithKline PLC's Net Change in Cash?
Net Change in Cash
-159m GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Net Change in Cash amounts to -159m GBP.

What is GlaxoSmithKline PLC's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
67%

Over the last year, the Net Change in Cash growth was 96%. The average annual Net Change in Cash growth rates for GlaxoSmithKline PLC have been 67% over the past three years .

Back to Top